Sandu Pharmaceuticals Ltd Share Price (524703)
as on
| Source : BSE
Sandu Pharmaceuticals Ltd Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹47₹48.49
2.89%
Downside
0.19%
Upside
52 Week's Low
52 Week's High
₹43.75₹69.59.61%
Downside
43.60%
Upside
| Market Stats | |
| Previous Close | ₹47.75 |
| Open | ₹47.56 |
| Volume | 665.00 |
| Upper Circuit | ₹57.30 |
| Lower Circuit | ₹38.20 |
| Day's Low | ₹47 |
| Day's High | ₹48.49 |
| 52 Week Low | ₹43.75 |
| 52 Week High | ₹69.5 |
| Returns % | |
| 1 Month Return | -6.08 % |
| 3 Month Return | -9.91 % |
| 1 Year Return | -18.34 % |
| 3 Year Return | -30 % |
| 5 Year Return | + 90.81 % |
Sandu Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Sandu Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹46.73 Cr
Return on Equity (ROE)
3.66
PE Ratio (TTM)
15.96
Return on capital employed (ROCE)
5.33
Industry PE ratio
43.28
Beta (LTM)
0.86
P/B Ratio
1.37
Dividend Yield
1.39
PEG Ratio
10.5
Quarterly Earnings Growth YOY
-44.07
EPS (TTM)
1.51
Sector
Pharmaceuticals
Book Value
42.02
Technical Analysis
Bearish
View Technical Analysis
Sandu Pharmaceuticals Ltd Stock's Interest Amongst Investors
Sandu Pharmaceuticals Ltd Stock Valuation
Track how Sandu Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Sandu Pharmaceuticals Ltd in the last 5 years
Lowest (13.97x)
March 27, 2025
Today (15.96x)
August 14, 2025
Industry (43.28x)
August 14, 2025
Highest (66.08x)
February 19, 2024
Today’s Price to Earnings Ratio: 15.96x
Sandu Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Sandu Pharmaceuticals Ltd, including revenue, profit, loss and more.
Sandu Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Sandu Pharmaceuticals Ltd.
Sandu Pharmaceuticals Ltd Earnings Results
Sandu Pharmaceuticals Ltd’s net profit fell -44.07% since last year same period to ₹0.33Cr in the Q4 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -41.07% fall in its net profits since last 3-months.
Read More about Earnings ResultsSandu Pharmaceuticals Ltd Dividends August,2024
In the quarter ending June 2024, Sandu Pharmaceuticals Ltd has declared dividend of ₹0.80 per share on 12 Aug 2024 - translating a dividend yield of 3.20%.
Read More about Dividends
Sandu Pharmaceuticals Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sandu Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 42.9% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 57.09% | 0.00 | |
| Others | 0.01% | 0.00 |
Sandu Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Sandu Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 46.73 | 18.16% | 0.50 | 1 | 67 | |
| NA | 138.38 | -10.52% | 0.00 | 12 | 69 | |
| NA | 48.85 | -16.67% | 0.00 | -22 | 104 | |
| NA | 48.17 | 105.43% | 0.00 | -1 | NA | |
| NA | 496.33 | 21.03% | 0.00 | NA | NA |
Sandu Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Sandu Pharmaceuticals Ltd.
Sandu Pharma Reports Decline in Sales and Profit - 03 Jun, 2025
Sandu Pharma's consolidated net sales for March 2025 fell 9.8% year-on-year to Rs 14.07 crore. Net profit decreased by 45.08% to Rs 0.33 crore, with EBITDA down 43.48%. The stock has shown negative returns of -8.07% over the last six months and -9.71% over the last year.
Insights on Sandu Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTRetail Holding Unchanged
Retail Investor holdings remained unchanged at 57.09% of holdings in Jun 2025 quarter
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.90% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 50.7%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.2% return, outperforming this stock by 160.2%
NEGATIVE IMPACTPrice Dip
In the last 3 years, Sandu Pharma. stock has moved down by -30.0%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 0.56 Cr → 0.33 Cr (in ₹), with an average decrease of 41.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 18.4 Cr → 14.14 Cr (in ₹), with an average decrease of 23.2% per quarter
About Sandu Pharmaceuticals Ltd
Revenue: ₹14.07Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.33Cr as on March 2025 (Q4 FY25)
Chairperson Name: K Vinay Kumar
| Organisation | Sandu Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | K Vinay Kumar |
| E-voting on shares | Click here to vote |
FAQs
What is Sandu Pharmaceuticals Ltd share price today?
Sandu Pharmaceuticals Ltd share price today stands at ₹48.4, Open: ₹47.56, Previous Close: ₹47.75, High: ₹48.49, Low: ₹47, 52 Week High: ₹69.5, 52 Week Low: ₹43.75 as on .
How to buy Sandu Pharmaceuticals Ltd shares ?
To buy Sandu Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 524703 or Sandu Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Sandu Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Sandu Pharmaceuticals Ltd?
Today's traded volume of Sandu Pharmaceuticals Ltd is 665.00. Which means that 665.00 shares of Sandu Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Sandu Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Sandu Pharmaceuticals Ltd is ₹46.73 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd’s 52 week high is ₹69.5 and 52 week low is ₹43.75. The current share price of Sandu Pharmaceuticals Ltd is ₹48.4, which is -30.36% down from its 52 week high and 10.63% up from its 52 week low.